Business Wire

ADVA

8.10.2019 09:02:06 CEST | Business Wire | Press release

Share
ADVA brings sub-microsecond synchronization to utility and broadcast networks

ADVA (FSE: ADV) today announced that it has extended the capabilities of its compact Oscilloquartz PTP timing technology to enable power utility and broadcast networks to achieve sub-microsecond synchronization. Now electricity companies can harness the accuracy needed for smart power grids, and media enterprises can meet key timing challenges. The two upgraded solutions are the pluggable OSA 5401 , the market’s smallest PTP grandmaster clock, and the highly versatile OSA 5405 , an integrated PTP grandmaster with dual GNSS antenna and receiver. Both technologies have proved critical in the telecommunications industry, where they have been widely deployed across the globe. They offer outstanding precision and unrivaled design density. Thanks to unique spoofing and jamming detection capabilities, they also provide unbeatable availability.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191008005048/en/

“This upgrade is big news for utility and media network operators looking to harness the most advanced innovation in their field. With our OSA 5401 and 5405 bringing new levels of accuracy and resilience to their infrastructure, they can reap the benefits of emerging bandwidth-intensive, latency-sensitive applications,” said Nir Laufer, senior director, product line management, Oscilloquartz, ADVA. “These devices are feature rich and incredibly efficient. But as well as their versatility, what really sets them apart is their extremely small footprint and low power consumption. This is key to bringing packet time distribution to the edge of network. With our technology ensuring sub-microsecond synchronization, smart grids can perform flexible, real-time decision making, as well as monitoring and automated maintenance. And for media companies, the possibilities for high-quality, interactive broadcasting from any location are enormous.”

The OSA 5401 and OSA 5405 now comply with the latest PTP profiles for time, frequency and phase synchronization in both power utility and broadcast networks . These include the IEC/IEEE 61850-9-3 Power Utility Profile for precise time distribution and clock synchronization in electrical grids with an accuracy of 1μs, and SMPTE 2059 for synchronizing video and audio equipment over packet networks. By supporting NTP, both solutions also enable enterprises to run an on-premises NTP server for high levels of accuracy and uncompromised availability. What’s more, the OSA 5401 and OSA 5405 include advanced GNSS jamming and spoofing detection mechanisms, which are integrated in a centralized AI-based GNSS assurance toolkit.

Taking up zero real estate and using very little power, the OSA 5401 can be deployed in the most space-restrictive locations. Its capabilities include multi-constellation GNSS (GPS/GLONASS/BEIDOU) and accurate time and frequency recovery, even in challenging environments such as urban canyons. Available in both indoor and outdoor variants, the OSA 5405 radically simplifies and extends the reach of GNSS antenna installation by allowing operators to forget about archaic and expensive RF cables and instead use simple Ethernet over copper cables or optical fiber. With the OSA 5405, highly precise GNSS-sourced synchronization is supported by network-based SyncE and PTP backups for highly stable sub-microsecond timing accuracy.

“Our mission is to make precise, resilient and affordable timing available in every industry. Both our OSA 5401 and OSA 5405 have had a significant impact on communication service provider networks, supporting mass small cell rollout and the transition to 5G connectivity. Now we’re ready to bring accurate, reliable and cost-efficient PTP timing to the edge of power and broadcast networks,” commented Ulrich Kohn, director, technical marketing, ADVA. “One feature of these devices that will prove key to network operators in these industries is their unique spoofing and jamming detection capabilities. These work on two layers. Firstly, network elements identify disruption autonomously. Then, on top of that, a layer powered by AI analyzes information from multiple devices. Using machine learning, this delivers the highly sophisticated and extremely robust protection needed for machine type communication applications in energy grid protection and control.”

Further information can be found in these slides: https://adva.li/power-and-broadcast-slides .

A supporting solution brief is also available: https://adva.li/broadcast-solution-brief .


About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we're building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .

About Oscilloquartz
Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to- end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA Optical Networking company, we're creating new opportunities for tomorrow's networks. For more information, please visit us at www.oscilloquartz.com .

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

Social Media:

https://www.facebook.com/ADVAOpticalNetworking

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye